US: (888) 231-0816

Emerging Life Sciences Virtual Event

Fast-track your journey from R&D to commercialization

In a complex, competitive, and fast-paced market, startups in biotechnology and biopharma, and early-stage medical device companies face many challenges on their journey from R&D to commercialization. Hosted by USDM Life Sciences in collaboration with Box, this virtual event provides valuable guidance and best practices to drive your compliance and technology strategy and roadmap.

Session 1 | IT & Quality Strategy & Roadmap

A discussion on trends in emerging life sciences technology and compliance.

  • Emerging industry trends in quality and technology
  • IT strategy and roadmap guidance
  • Quality considerations in early-stage planning
  • Regulatory implication of the FDA’s CSA guidance
  • Live Q&A


  • Roger Davy, Director Customer Engagement, USDM
  • Paula Dawson, Senior Program Manager, USDM
  • Dom Glavach, Chief Security Officer and Chief Security Strategist, CyberSN
  • Matt Webb, Interim CIO, Elevar Therapeutics

Watch a highlight clip from Session 1 below:

Session 2 | Maintaining Cloud Compliance & Enabling Automation

How to manage your GxP cloud workloads to enable automation and create more efficient GxP business processes.

  • An integrated approach to Quality & IT
  • USDM framework for compliance to enable a continuously compliant tech stack
  • Quality orchestration through automation
  • Live Q&A


Watch this short clip to see a highlight from Session 2:

Session 3 | Compliant Cloud Content Management

Businesses run on content. Learn how content and documents can be managed and shared while staying secure.

  • GxP and CSA compliance for content management
  • How customers are using cloud content management to achieve efficiency and security
  • What the right technology can do to help achieve virtual audit success
  • Live Q&A


Watch this short clip to see a highlight from Session 3:

Please email with any questions.

Watch On Demand

Please fill out the form to access.

Want to talk with our
subject matter experts?